We scan new podcasts and send you the top 5 insights daily.
The scientific-sounding term "hypothesis" creates a sense of ownership that causes founders to defend their idea and make minor tweaks, rather than objectively seeking truth. An "anecdote" is external and easier to discard if it doesn't repeat.
The goal of early validation is not to confirm your genius, but to risk being proven wrong before committing resources. Negative feedback is a valuable outcome that prevents building the wrong product. It often reveals that the real opportunity is "a degree to the left" of the original idea.
The word "hypothesis" encourages founders to invent plausible but flawed ideas in a vacuum. Switching to "anecdotes" forces the starting point to be a real customer story, shifting the goal from validating an idea to seeing if a real-world event repeats.
The common phrase 'the plural of anecdote is not data' is flawed. Data is essentially formalized anecdotes that reveal a repeatable pattern. Early, informal observations from credible sources are often the precursors to verifiable data and shouldn't be dismissed outright.
Much published research is false because scientists find correlations and then create a hypothesis retrospectively, like drawing a bullseye around a bullet hole. Requiring predictions *before* data collection forces intellectual honesty, a practice valuable for business A/B testing and market research.
Don't start with a rigid belief in your solution. Begin with a problem hypothesis and use customer feedback to discover the right answer. Getting your product out quickly and being humble enough to accept harsh feedback is critical to finding the truth before you run out of time.
Instead of seeking validation, leaders should test their strategy like a scientist. Formulate a specific hypothesis about customer value, commit to a clear test and a decision rule beforehand, and be prepared to pivot if the data proves the hypothesis wrong. This avoids confirmation bias.
PE investors and leadership teams often fall in love with their initial value creation plan. Calling it a "thesis" creates rigidity. Re-framing it as a "hypothesis" encourages a mindset of testing, learning, and adapting to market realities, which is what actually happens every time.
A 'thesis' is a belief to be defended, leading to confirmation bias. A 'hypothesis' is a quantitatively falsifiable statement that invites challenge. This simple linguistic shift fosters a culture of actively seeking disconfirming evidence, leading to more rational investment decisions.
The fastest way to de-risk a biotech concept is to actively try to 'kill' it. By pitching to experts and seeking critical feedback in competitions, founders can expose fatal flaws early. If the idea is invalidated, it saves years of wasted effort; if it survives, it's significantly stronger.
The most successful founders rarely get the solution right on their first attempt. Their strength lies in persistence combined with adaptability. They treat their initial ideas as hypotheses, take in new data, and are willing to change their approach repeatedly to find what works.